AbbVie Inc. Blog | Talkmarkets | Page 1

AbbVie Inc.

Get instant email alerts
Exchange: Sector: Industry:
NYSE

People who follow this stock (102)

Latest Posts

About This Stock More About This Stock
Stocks To Trade: RACE ABBV DYN
Article By: Ryan Mallory
Thursday, February 15, 2018 6:00 AM EST
Take a look at three trading ideas to prep you for the next trading session.
In this article: DYN, ABBV, RACE
Read
IBB – Challenging 2016, Recovering 2017 And Resurgence In 2018
Article By: Noah Kiedrowski
Tuesday, February 6, 2018 3:12 PM EST
The Biotechnology cohort has finally notched a 52-week high and has made up much of the lost ground during the pummeling from both sides of the political isle during the 2016 presidential race.
In this article: AGN, JNJ, NVO, IBB, REGN, GILD, JUNO, ABBV, KITE
Read
How Bad Was The Biotech Selloff Last Week?
Article By: Rod Raynovich
Sunday, February 4, 2018 5:30 PM EST
Biotech stocks got hit with a double whammy from concerns about high prices and disruption in healthcare from reform. But biotech investors made money last year and are still in the green for 2018 even after many stocks reported earnings.
In this article: BIIB, CELG, GILD, ABBV, IBB, FBT, XBI, XLV, BLUE
Read
AbbVie - Chart Of The Day
Article By: Jim Van Meerten
Sunday, January 28, 2018 12:08 PM EST
The Chart of the Day belongs to AbbVie (ABBV), a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader.
In this article: ABBV
Read
Abbvie Earnings Drive Biotech Stocks Higher With Large Caps Dominant
Article By: Rod Raynovich
Friday, January 26, 2018 6:44 PM EST
Biotech stocks soared again today to new highs driven by Abbvie Inc. earnings and overall sector strength. Momentum was strong in the general market with NASDAQ up 1.28% and the S&P up 1.18%. The M&A theme should be the driver in 2017.
In this article: IBB, REGN, BIIB, NBIX, XBI, ICPT, ESPR, ABBV, PTLA
Read

PARTNER HEADLINES

Latest Tweets for $ABBV

No tweets yet!

$ABBV

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 1 of 1 comments